A global rank end point for clinical trials in acute heart failure.
Publication
, Journal Article
Felker, GM; Maisel, AS
Published in: Circ Heart Fail
September 2010
Duke Scholars
Published In
Circ Heart Fail
DOI
EISSN
1941-3297
Publication Date
September 2010
Volume
3
Issue
5
Start / End Page
643 / 646
Location
United States
Related Subject Headings
- Research Design
- Humans
- Heart Failure
- Endpoint Determination
- Clinical Trials as Topic
- Cardiovascular System & Hematology
- Biomarkers
- Acute Disease
- 3208 Medical physiology
- 3201 Cardiovascular medicine and haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Felker, G. M., & Maisel, A. S. (2010). A global rank end point for clinical trials in acute heart failure. Circ Heart Fail, 3(5), 643–646. https://doi.org/10.1161/CIRCHEARTFAILURE.109.926030
Felker, G Michael, and Alan S. Maisel. “A global rank end point for clinical trials in acute heart failure.” Circ Heart Fail 3, no. 5 (September 2010): 643–46. https://doi.org/10.1161/CIRCHEARTFAILURE.109.926030.
Felker GM, Maisel AS. A global rank end point for clinical trials in acute heart failure. Circ Heart Fail. 2010 Sep;3(5):643–6.
Felker, G. Michael, and Alan S. Maisel. “A global rank end point for clinical trials in acute heart failure.” Circ Heart Fail, vol. 3, no. 5, Sept. 2010, pp. 643–46. Pubmed, doi:10.1161/CIRCHEARTFAILURE.109.926030.
Felker GM, Maisel AS. A global rank end point for clinical trials in acute heart failure. Circ Heart Fail. 2010 Sep;3(5):643–646.
Published In
Circ Heart Fail
DOI
EISSN
1941-3297
Publication Date
September 2010
Volume
3
Issue
5
Start / End Page
643 / 646
Location
United States
Related Subject Headings
- Research Design
- Humans
- Heart Failure
- Endpoint Determination
- Clinical Trials as Topic
- Cardiovascular System & Hematology
- Biomarkers
- Acute Disease
- 3208 Medical physiology
- 3201 Cardiovascular medicine and haematology